Second phase III trial of PRF-110 for post-operative pain relief in soft and hard tissue.
Phase of Trial: Phase III
Latest Information Update: 24 Jul 2018
Price : $35 *
At a glance
- Drugs Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 24 Jul 2018 New trial record
- 18 Jul 2018 According to a PainReform media release, company received FDA approval to conduct two pivotal Phase III clinical trials for post-operative pain relief in soft and hard tissue.